The manufacturer of Nurofen, Reckitt Benckiser, has been fined A$1.7m ($1.3m; £0.89m) in Australia for misleading customers.
Australia's Federal Court ruled last year that products marketed as targeting specific pains, such as migraine, were actually identical.
